← All Claims

Clinical trial data for peptides often shows flashing on-and-off benefits because many have only completed Stage 2 or Stage 3 trials without full FDA approval, creating uncertain risk-benefit profiles

factualpending

Speaker

Dr. Kyle Gillette

Evidence Quote

“whenever there's not an approved indication and it hasn't been through all three stages of clinical trials and gotten approved then you want the theoretical risks to be as low as possible”

Source

Complete Guide to Peptides for Fat Loss, Muscle Building & Longevity | Dr. Kyle Gillett MD— Thomas DeLauer
Created: 8/13/2026, 4:51:25 AM

My Notes

Loading notes...